A 65-year-old ex-smoker with COPD, FEV1 45 percent predicted, remains symptomatic on a SABA. Which inhaled therapy is recommended next according to NI...

Question

A 65-year-old ex-smoker with COPD, FEV1 45 percent predicted, remains symptomatic on a SABA. Which inhaled therapy is recommended next according to NICE

Accepted Answer

Long-acting beta-2 agonist plus inhaled corticosteroid

Answer

Oral steroids

Answer

Long-acting muscarinic antagonist alone

Answer

Theophylline

Answer

Montelukast

ukmla MCQ (SBA): COPD

A 65-year-old ex-smoker with COPD, FEV1 45 percent predicted, remains symptomatic on a SABA. Which inhaled therapy is recommended next according to NICE